Stock market Updates | Syncom Formulations (India) Ltd. | R Wadiwala Securities Pvt Ltd

SYNCOM FORMULATIONS (INDIA) LTD.

NSE : SYNCOMFBSE : 524470ISIN CODE : INE312C01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE17.67-0.03 (-0.17 %)
PREV CLOSE (Rs.) 17.70
OPEN PRICE (Rs.) 17.98
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 183803
TODAY'S LOW / HIGH (Rs.)17.45 17.98
52 WK LOW / HIGH (Rs.)14.1 27.94
NSE17.64-0.06 (-0.34 %)
PREV CLOSE( Rs. ) 17.70
OPEN PRICE (Rs.) 17.84
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 17.64 (40)
VOLUME 488318
TODAY'S LOW / HIGH(Rs.) 17.60 17.95
52 WK LOW / HIGH (Rs.)14.1 27.9

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
32.51
Dividend Yield(%)
0.00
TTM EPS (Rs.)
0.61
P/E Ratio
29.15
Book Value (Rs.)
3.78
Face Value (Rs.)
1
MCap (Rs. in Mn)
16609.80
Price/Earning (TTM)
26.70
Price/Sales (TTM)
3.37
Price/Book (MRQ)
4.67
PAT Margin (%)
9.14
ROCE (%)
10.46
company info
Incorporation Year : 21-06 1988

Management Info :

Kedarmal Bankda - Chairman Vijay Shankarlal Bankda - Managing Director

Registered Office :

Address : 7 Niraj Industrial Estate,Off Mahakali Caves Road,Andheri (E),
Mumbai,
Maharashtra-400093

Phone : 022 30887744 / 54

Website : www.sfil.in

Registrars Details :

Ankit Consultancy Pvt Ltd
Plot No 60,Electronic Complex,Pardeshipura,Indore
Listing : BSE, NSE
News
11Feb Syncom Formulations (India) submits ne
Pursuant to Regulation 30 read with Schedule III Part A(A) and in compli..
02Jul Syncom Formulations (India) informs ab
Syncom Formulations (India) has informed that the Share Transfer Agent o..
09May Syncom Formulations (India) submits bo
Syncom Formulations (India) has informed that pursuant to Regulation 29(..
Financials
QTR Jun 25 ANNUAL 25
Net Profit157.3488.72
Gross Profit 202.59 646.59
Operating Profit 217.95 706.97
Net Sales 1165.47 4628.49
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
Abbott India (BSE)
Rwadiwala-peer-arrow  32986.65 (1.99%)
M.Cap (Rs. in Cr)70094.33
Alkem Laboratories (BSE)
Rwadiwala-peer-arrow  5390.90 (4.66%)
M.Cap (Rs. in Cr)64456.30
Glaxosmithkline Phar (BSE)
Rwadiwala-peer-arrow  2773.70 (7.13%)
M.Cap (Rs. in Cr)46988.15
Divi's Lab (BSE)
Rwadiwala-peer-arrow  6103.40 (2.39%)
M.Cap (Rs. in Cr)162026.09
Shareholding Pattern
PROMOTERS
50.57%
NON-INSTITUTION
49.02%
MUTUAL FUNDS/UTI
0%
FI/BANKS/INSURANCE
0%
GOVERNMENT
0%
FII
0%
Mf Holdings